Review
Published on 08 Dec 2022
A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1036437
- 4,891 views
- 6 citations
Type at least 3 characters
1,748 articles
Articles
Perspective
Published on 08 Dec 2022
Canadian perspectives in multiple myeloma on the use of steroids in clinical practice based on patient and healthcare provider interviews
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1061417
- 3,140 views
- 3 citations
Case Report
Published on 08 Dec 2022
Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.986144
- 1,189 views
Original Research
Published on 08 Dec 2022
High efficacy of azacitidine combined with homoharringtonine, idarubicin, and cytarabine in newly diagnosed patients with AML: A single arm, phase 2 trial
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1069246
- 1,672 views
- 2 citations
Case Report
Published on 07 Dec 2022
Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1014671
- 3,841 views
- 3 citations
Original Research
Published on 07 Dec 2022
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.939819
- 1,555 views
- 1 citation
Original Research
Published on 06 Dec 2022
The immune checkpoint expression in the tumor immune microenvironment of DLBCL: Clinicopathologic features and prognosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1069378
- 2,126 views
- 9 citations
Case Report
Published on 05 Dec 2022
Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1069977
- 1,483 views
Original Research
Published on 02 Dec 2022
Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1044539
- 2,341 views
- 5 citations
Brief Research Report
Published on 02 Dec 2022
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.897937
- 2,140 views
- 4 citations
Perspective
Published on 01 Dec 2022
Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1062296
- 2,378 views
- 3 citations
Original Research
Published on 01 Dec 2022
Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1013781
- 1,832 views
- 1 citation
Original Research
Published on 01 Dec 2022
Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1032336
- 5,232 views
- 4 citations
Original Research
Published on 01 Dec 2022
CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1061438
- 3,604 views
- 4 citations
Brief Research Report
Published on 30 Nov 2022
Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1056293
- 3,901 views
- 1 citation
Review
Published on 30 Nov 2022
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1066285
- 2,829 views
- 3 citations